Iris Morr

659 total citations
14 papers, 496 citations indexed

About

Iris Morr is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Iris Morr has authored 14 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Iris Morr's work include Virus-based gene therapy research (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and RNA Interference and Gene Delivery (3 papers). Iris Morr is often cited by papers focused on Virus-based gene therapy research (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and RNA Interference and Gene Delivery (3 papers). Iris Morr collaborates with scholars based in Germany and Austria. Iris Morr's co-authors include Annette Altmann, Uwe Haberkorn, G. van Kaick, Franz Oberdorfer, Shiming Jiang, Matthias E. Bellemann, Uwe Haberkorn, J. Blatter, Marcus Henze and Gunnar Brix and has published in prestigious journals such as Magnetic Resonance in Medicine, European Journal of Nuclear Medicine and Molecular Imaging and Gene Therapy.

In The Last Decade

Iris Morr

14 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Morr Germany	12	230	208	161	100	86	14	496
Corrina M.A. de Ridder Netherlands	12	189 0.8×	75 0.4×	112 0.7×	115 1.1×	204 2.4×	23	519
J B Little United States	14	336 1.5×	54 0.3×	234 1.5×	124 1.2×	272 3.2×	22	620
R. A. Berjian United States	7	208 0.9×	54 0.3×	45 0.3×	70 0.7×	222 2.6×	13	434
Robert Daber United States	15	315 1.4×	160 0.8×	37 0.2×	182 1.8×	87 1.0×	35	673
Mary Ann Quinn-Allen United States	16	235 1.0×	100 0.5×	44 0.3×	40 0.4×	79 0.9×	21	879
Joseph M. Cantor United States	13	308 1.3×	87 0.4×	36 0.2×	60 0.6×	127 1.5×	21	699
Dennise P. Calkins United States	7	208 0.9×	52 0.3×	61 0.4×	216 2.2×	80 0.9×	9	410
Kazuhiro Daino Japan	15	267 1.2×	68 0.3×	235 1.5×	136 1.4×	147 1.7×	53	575
G. Robinson United States	4	343 1.5×	40 0.2×	180 1.1×	113 1.1×	88 1.0×	4	598
Anamaria Rojas United Kingdom	9	146 0.6×	53 0.3×	61 0.4×	93 0.9×	66 0.8×	11	361

Countries citing papers authored by Iris Morr

Since Specialization

Citations

This map shows the geographic impact of Iris Morr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Morr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Morr more than expected).

Fields of papers citing papers by Iris Morr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Morr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Morr. The network helps show where Iris Morr may publish in the future.

Co-authorship network of co-authors of Iris Morr

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Morr. A scholar is included among the top collaborators of Iris Morr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Morr. Iris Morr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Haberkorn, Uwe, Marcus Henze, Annette Altmann, et al.. (2001). Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.. PubMed. 42(2). 317–25. 90 indexed citations

Haberkorn, Uwe, Matthias E. Bellemann, Gunnar Brix, et al.. (2001). Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabine. European Journal of Nuclear Medicine and Molecular Imaging. 28(4). 418–425. 34 indexed citations

Haberkorn, Uwe, et al.. (2001). Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene. European Journal of Nuclear Medicine and Molecular Imaging. 28(5). 633–638. 21 indexed citations

Haberkorn, Uwe, Annette Altmann, Huse Kamencic, et al.. (2001). Glucose transport and apoptosis after gene therapy with HSV thymidine kinase. European Journal of Nuclear Medicine and Molecular Imaging. 28(11). 1690–1696. 27 indexed citations

Haberkorn, Uwe, Khashayarsha Khazaie, Iris Morr, et al.. (1998). Ganciclovir Uptake in Human Mammary Carcinoma Cells Expressing Herpes Simplex Virus Thymidine Kinase. Nuclear Medicine and Biology. 25(4). 367–373. 34 indexed citations

Haberkorn, Uwe, et al.. (1998). Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo³¹P NMR and in vitro uptake experiments. Magnetic Resonance in Medicine. 39(5). 754–761. 3 indexed citations

Haberkorn, Uwe, Iris Morr, H Trojan, et al.. (1998). Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Therapy. 5(7). 880–887. 28 indexed citations

Shields, Anthony F., et al.. (1998). 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.. PubMed. 39(8). 1418–23. 9 indexed citations

Haberkorn, Uwe, et al.. (1997). Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates.. PubMed. 38(2). 287–94. 59 indexed citations

10.

Haberkorn, Uwe, et al.. (1997). Multitracer studies during gene therapy of hepatoma cells with herpes simplex virus thymidine kinase and ganciclovir.. PubMed. 38(7). 1048–54. 19 indexed citations

11.

Haberkorn, Uwe, Matthias E. Bellemann, Annette Altmann, et al.. (1997). PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.. PubMed. 38(8). 1215–21. 38 indexed citations

12.

Schaider, Helmut, Uwe Haberkorn, Martin R. Berger, et al.. (1996). Application of α-aminoisobutyric acid,l-methionine, thymidine and 2-fluoro-2-deoxy-d-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. European Journal of Nuclear Medicine and Molecular Imaging. 23(1). 55–60. 17 indexed citations

13.

Haberkorn, Uwe, Franz Oberdorfer, Johannes Gebert, et al.. (1996). Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.. PubMed. 37(1). 87–94. 69 indexed citations

14.

Haberkorn, Uwe, Iris Morr, Franz Oberdorfer, et al.. (1994). Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine.. PubMed. 35(11). 1842–50. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact